Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device

Clinical trial NCT01618955 · COMPLETED

Trial details

NCT number: NCT01618955
Sponsor: Antares Pharma Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)

Start date: 2012-05-01
Primary completion: 2012-07-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.